Report Categories
View AllRecent Articles
View All
ALKT Alkami shares climb 241 percent following Q1 2026 earnings despite 133 percent EPS miss against consensus estimates
Xcel Energy XEL Valuation Disparity Emerges Amid Balanced Growth Drivers and Downside Risks
NUTX Nutex Health posts steep 752 percent Q4 2025 EPS miss shares dip slightly in todays trading
SEAT Vivid Seats reports massive Q4 2025 earnings miss shares climb 737 percent in todays trading
IBM Surges on Trump Administrations 2 Billion Quantum Computing Initiative
Indian Government to Divest 2 Stake in Coal India via Offer for Sale at Rs 412 Floor Price
Prediction Market Investments Continue Despite Regulatory Uncertainty
Crossroads Capital Investment Maintains Constructive Outlook on FTAI Aviation
SpaceX Filing Details Performance Milestones for Elon Musks Potential Billions
Boeings LongTerm Trajectory Analyst Perspectives on the Next Decade
MakeMyTrip Q1 2026 Earnings EPS Miss Despite Stable Travel Demand
VICR Q1 2026 Earnings EPS Surges Past Estimates with 1983 Beat
CVSA Q1 2026 Earnings Strong EPS Surprise Drives Positive Stock Reaction
SHIP Q4 2025 Earnings EPS Surprises to the Upside Amid Robust Dry Bulk Market
HBM Q1 2026 Earnings EPS Beats Estimates as Stock Rallies
RCON Q4 2025 Earnings EPS Surprise Beats Estimates Amid Revenue Uncertainty
CBL Associates Properties CBL Holds Near 47 After Fractional Decline
Hennessy Capital Investment Corp VII Unit HVIIU Holds Steady at 1080 Stable Trading in a Calm Market
Evolution Global Acquisition Corp EVOXU Holds Steady at 1017 SPAC Units Trade in Tight Range
T Stamp Inc IDAI Gains 39 as Buyers Test Key Resistance at 252
Hawkins Inc HWKN Posts Solid Gains Approaching Key Resistance Amid Strong Momentum
CRNC Q1 2026 Earnings EPS Beats Estimates Amidst Modest Stock Uptick
SBDS Q1 2026 Earnings Significant Loss Reported Amidst Operational Challenges
NAVI Q1 2026 Earnings EPS Beat Drives Positive Stock Response
INLX Q1 2026 Earnings Significant EPS Miss Highlights Operational Headwinds
EVH Q1 2026 Earnings EPS Surpasses Expectations with 614 Surprise
RenovoRx Q1 2026 Earnings EPS Miss as PreRevenue Biotech Continues Clinical Development